Furthermore, CARD9 mutation in IBD results in a decrease in the production of pro-inflammatory cytokines (IL-6, TNFα and IFNγ) and Th17 and innate lymphoid cell-ILC-related cytokines (IL-17A, IL-17F, IL-22) [84,85,86]. The gene discussed is TNF; the disease is inflammatory bowel disease.